Middle East respiratory syndrome coronavirus infection chest x ray: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
(12 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Radiographic]] findings [[MERS-CoV]] [[infection]] include unilateral or bilateral patchy densities or opacities, interstitial infiltrates, consolidation] and [[pleural effusions]]. | |||
==Chest X Ray== | ==Chest X Ray== | ||
MERS-CoV infection causes [[atypical pneumonia]] characterized by diffuse [[alveolar]] damage with the potential to progress to [[ARDS]].<ref>{{Cite journal | [[MERS-CoV]] [[infection]] causes [[atypical pneumonia]] characterized by diffuse [[alveolar]] damage with the potential to progress to [[ARDS]].<ref>{{Cite journal | ||
| doi = 10.7326/M13-2486 | | doi = 10.7326/M13-2486 | ||
| issn = 1539-3704 | | issn = 1539-3704 | ||
Line 22: | Line 21: | ||
| date = 2014-03-18 | | date = 2014-03-18 | ||
| pmid = 24474051 | | pmid = 24474051 | ||
}}</ref> Chest X ray findings may range from focal to extensive abnormalities including:<ref>{{Cite journal | }}</ref> [[Chest X ray]] findings may range from focal to extensive abnormalities including:<ref>{{Cite journal | ||
| doi = 10.1016/S1473-3099(13)70204-4 | | doi = 10.1016/S1473-3099(13)70204-4 | ||
| issn = 1474-4457 | | issn = 1474-4457 | ||
Line 35: | Line 34: | ||
| date = 2013-09 | | date = 2013-09 | ||
| pmid = 23891402 | | pmid = 23891402 | ||
}}</ref> | }}</ref><ref name="AjlanAhyad2014">{{cite journal|last1=Ajlan|first1=Amr M.|last2=Ahyad|first2=Rayan A.|last3=Jamjoom|first3=Lamia Ghazi|last4=Alharthy|first4=Ahmed|last5=Madani|first5=Tariq A.|title=Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: Chest CT Findings|journal=American Journal of Roentgenology|year=2014|pages=1–6|issn=0361-803X|doi=10.2214/AJR.14.13021}}</ref><ref name="AssiriAl-Tawfiq2013">{{cite journal|last1=Assiri|first1=Abdullah|last2=Al-Tawfiq|first2=Jaffar A|last3=Al-Rabeeah|first3=Abdullah A|last4=Al-Rabiah|first4=Fahad A|last5=Al-Hajjar|first5=Sami|last6=Al-Barrak|first6=Ali|last7=Flemban|first7=Hesham|last8=Al-Nassir|first8=Wafa N|last9=Balkhy|first9=Hanan H|last10=Al-Hakeem|first10=Rafat F|last11=Makhdoom|first11=Hatem Q|last12=Zumla|first12=Alimuddin I|last13=Memish|first13=Ziad A|title=Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study|journal=The Lancet Infectious Diseases|volume=13|issue=9|year=2013|pages=752–761|issn=14733099|doi=10.1016/S1473-3099(13)70204-4}}</ref><ref name="ArabiArifi2014">{{cite journal|last1=Arabi|first1=Yaseen M.|last2=Arifi|first2=Ahmed A.|last3=Balkhy|first3=Hanan H.|last4=Najm|first4=Hani|last5=Aldawood|first5=Abdulaziz S.|last6=Ghabashi|first6=Alaa|last7=Hawa|first7=Hassan|last8=Alothman|first8=Adel|last9=Khaldi|first9=Abdulaziz|last10=Al Raiy|first10=Basel|title=Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection|journal=Annals of Internal Medicine|volume=160|issue=6|year=2014|pages=389-397|issn=0003-4819|doi=10.7326/M13-2486}}</ref> | ||
* Basal pleural thickening | * Basal [[pleural]] thickening | ||
* Bronchial wall thickening | * [[Bronchial]] wall thickening | ||
* [[Pulmonary consolidation]] | * [[Pulmonary consolidation]] | ||
* Increased bronchovascular markings | * Increased bronchovascular markings | ||
Line 45: | Line 44: | ||
* [[Pleural effusion]]s | * [[Pleural effusion]]s | ||
* Reticulo-nodular airspace opacities | * Reticulo-nodular airspace opacities | ||
* Total opacification of [[Bronchopulmonary segment|lung segments]] and lobes | * Total opacification of [[Bronchopulmonary segment|lung segments]] and [[lobes]] | ||
==References== | ==References== | ||
Line 52: | Line 51: | ||
[[category:disease]] | [[category:disease]] | ||
[[category:virology]] | [[category:virology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] |
Latest revision as of 18:04, 18 September 2017
Middle East Respiratory Syndrome Coronavirus Infection Microchapters |
Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Middle East respiratory syndrome coronavirus infection chest x ray On the Web |
American Roentgen Ray Society Images of Middle East respiratory syndrome coronavirus infection chest x ray |
FDA on Middle East respiratory syndrome coronavirus infection chest x ray |
CDC on Middle East respiratory syndrome coronavirus infection chest x ray |
Middle East respiratory syndrome coronavirus infection chest x ray in the news |
Blogs on Middle East respiratory syndrome coronavirus infection chest x ray |
Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Radiographic findings MERS-CoV infection include unilateral or bilateral patchy densities or opacities, interstitial infiltrates, consolidation] and pleural effusions.
Chest X Ray
MERS-CoV infection causes atypical pneumonia characterized by diffuse alveolar damage with the potential to progress to ARDS.[1] Chest X ray findings may range from focal to extensive abnormalities including:[2][3][4][5]
- Basal pleural thickening
- Bronchial wall thickening
- Pulmonary consolidation
- Increased bronchovascular markings
- Interstitial changes
- Patchy infiltrates
- Pleural effusions
- Reticulo-nodular airspace opacities
- Total opacification of lung segments and lobes
References
- ↑ Arabi, Yaseen M (2014-03-18). "Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection". Annals of internal medicine. 160 (6): 389–397. doi:10.7326/M13-2486. ISSN 1539-3704. PMID 24474051. Unknown parameter
|coauthors=
ignored (help) - ↑ Assiri, Abdullah (2013-09). "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study". The Lancet infectious diseases. 13 (9): 752–761. doi:10.1016/S1473-3099(13)70204-4. ISSN 1474-4457. PMID 23891402. Unknown parameter
|coauthors=
ignored (help); Check date values in:|date=
(help) - ↑ Ajlan, Amr M.; Ahyad, Rayan A.; Jamjoom, Lamia Ghazi; Alharthy, Ahmed; Madani, Tariq A. (2014). "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: Chest CT Findings". American Journal of Roentgenology: 1–6. doi:10.2214/AJR.14.13021. ISSN 0361-803X.
- ↑ Assiri, Abdullah; Al-Tawfiq, Jaffar A; Al-Rabeeah, Abdullah A; Al-Rabiah, Fahad A; Al-Hajjar, Sami; Al-Barrak, Ali; Flemban, Hesham; Al-Nassir, Wafa N; Balkhy, Hanan H; Al-Hakeem, Rafat F; Makhdoom, Hatem Q; Zumla, Alimuddin I; Memish, Ziad A (2013). "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study". The Lancet Infectious Diseases. 13 (9): 752–761. doi:10.1016/S1473-3099(13)70204-4. ISSN 1473-3099.
- ↑ Arabi, Yaseen M.; Arifi, Ahmed A.; Balkhy, Hanan H.; Najm, Hani; Aldawood, Abdulaziz S.; Ghabashi, Alaa; Hawa, Hassan; Alothman, Adel; Khaldi, Abdulaziz; Al Raiy, Basel (2014). "Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection". Annals of Internal Medicine. 160 (6): 389–397. doi:10.7326/M13-2486. ISSN 0003-4819.